Vericel (VCEL) Other financing activities (2010 - 2026)
Vericel's (VCEL) quarterly Other financing activities came in at -$21000.0 in Q1 2026, down 425.0% year-on-year from $6461.5 in Q1 2025, and little changed quarter-over-quarter from -$21000.0 in Q4 2025.
Vericel (VCEL) Other financing activities (2010 - 2026) Analysis & Trends
Vericel has disclosed Other financing activities across 11 years of filings, most recently posting -$21000.0 for Q1 2026.
- Other financing activities for Q1 2026 came in at -$21000.0, down 425.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$64000.0 (down 1500.0% YoY), and the FY2025 annual result was -$47000.0, changed N/A from the prior year.
- Other financing activities came in at -$21000.0 for Q1 2026 at Vericel, roughly flat from -$21000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1000.0 in Q2 2022 to a low of -$21000.0 in Q3 2022.
- The 4-year median for Other financing activities is -$19000.0 (2022), against an average of -$13454.5.
- Across the five-year window, Other financing activities changed 0.0% in 2023 and slumped 425.0% in 2026, its largest moves.
- Vericel's Other financing activities stood at -$21000.0 in 2022, then changed by 0.0% to -$21000.0 in 2023, then changed by 0.0% to -$21000.0 in 2025, then changed by 0.0% to -$21000.0 in 2026.
- The last three Other financing activities figures came in at -$21000.0 (Q1 2026), -$21000.0 (Q4 2025), and -$11000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Dec 31, 2025 | -21,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Sep 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Mar 31, 2023 | -21,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Sep 30, 2022 | -21,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |